The role of autophagy in chemotherapy resistance of cisplatin in ovarian cancer

被引：0
|
作者：
Alsoulaiman, Lamak [1 ]
Biktagirova, Elnara [2 ]
Abramova, Zinaida [2 ]
机构：
[1] Moscow Inst Phys & Technol, Moscow, Russia
[2] Kazan Fed Univ, Kazan, Russia
来源：
CELL DEATH DISCOVERY | 2021年 / 7卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
1
引用
收藏
页码：1 / 1
页数：1
相关论文
共 50 条
  • [31] Mechanisms of chemotherapy resistance in ovarian cancer
    Ortiz, Mylena
    Wabel, Emma
    Mitchell, Kerry
    Horibata, Sachi
    CANCER DRUG RESISTANCE, 2022, 5 (02) : 304 - 316
  • [32] Combination of FTY720 with cisplatin exhibits antagonistic effects in ovarian cancer cells: Role of autophagy
    Zhang, Ning
    Dai, Lan
    Qi, Yanfei
    Di, Wen
    Xia, Pu
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2013, 42 (06) : 2053 - 2059
  • [33] INVESTIGATING THE ROLE OF LONG NON-CODING RNAS IN CISPLATIN RESISTANCE IN OVARIAN CANCER
    Shah, Jaynish S.
    Cole, Alexander J.
    Dickson, Kristie-Ann
    Soon, Patsy
    Marsh, Deborah J.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 42 - 42
  • [34] The role of RBPMS in cisplatin resistant ovarian cancer
    Baez-Vega, Perla M.
    Valiyeva, Fatma
    Santiago, Ginette
    Vivas-Mejia, Pablo
    CANCER RESEARCH, 2017, 77
  • [35] Lung cancer cells and their sensitivity/resistance to cisplatin chemotherapy: Role of microRNAs and upstream mediators
    Ashrafizadeh, Milad
    Zarrabi, Ali
    Hushmandi, Kiavash
    Hashemi, Farid
    Moghadam, Ebrahim Rahmani
    Owrang, Marzieh
    Hashemi, Fardin
    Makvandi, Pooyan
    Goharrizi, Mohammad Ali Sheikh Beig
    Najafi, Masoud
    Khan, Haroon
    CELLULAR SIGNALLING, 2021, 78
  • [36] Downregulation of BAG3 attenuates cisplatin resistance by inhibiting autophagy in human epithelial ovarian cancer cells
    Qiu, Shuang
    Sun, Liang
    Zhang, Yan
    Han, Shiyu
    ONCOLOGY LETTERS, 2019, 18 (02) : 1969 - 1978
  • [37] Role of chemotherapy in relapsed ovarian cancer
    Colombo, N
    Parma, G
    Bocciolone, L
    Sideri, M
    Franchi, D
    Maggioni, A
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 1999, 32 (03) : 221 - 228
  • [38] Prognostic significance of sVEGFR-1 in identification of resistance to cisplatin and paclitaxel chemotherapy in ovarian cancer patients
    Bednarek, Wieslawa
    Barczynski, Bartlomiej
    Kotarski, Jan
    MENOPAUSE REVIEW-PRZEGLAD MENOPAUZALNY, 2005, 4 (05): : 65 - 71
  • [39] The role of neoadjuvant chemotherapy in ovarian cancer
    Elies, Antoine
    Riviere, Sophie
    Pouget, Nicolas
    Becette, Veronique
    Dubot, Coraline
    Donnadieu, Anne
    Rouzier, Roman
    Bonneau, Claire
    EXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (06) : 555 - 566
  • [40] Increased basal autophagy decreases sensitivity to cisplatin in chemoresistant ovarian cancer
    Silvers, Thomas R.
    Dottino, Peter R.
    Martignetti, John A.
    Evans, Brad R.
    CLINICAL CANCER RESEARCH, 2016, 22
12345